Found: 13
Select item for more details and to access through your institution.
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-021-02709-2
- By:
- Publication type:
- Article
The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01896
- By:
- Publication type:
- Article
Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 2, p. 268, doi. 10.1002/art.42677
- By:
- Publication type:
- Article
Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 8, p. 1387, doi. 10.1002/art.42111
- By:
- Publication type:
- Article
Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 6, p. 972, doi. 10.1002/art.40815
- By:
- Publication type:
- Article
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 11, p. 2209, doi. 10.1002/art.40229
- By:
- Publication type:
- Article
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03143-2
- By:
- Publication type:
- Article
Deletion of the Fission Yeast Homologue of Human Insulinase Reveals a TORC1-Dependent Pathway Mediating Resistance to Proteotoxic Stress.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067705
- By:
- Publication type:
- Article
Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232978
- By:
- Publication type:
- Article
Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41943-3
- By:
- Publication type:
- Article
Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41943-3
- By:
- Publication type:
- Article
Corrigendum: The Nrf2 -Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1694-9
- By:
- Publication type:
- Article